Uroplasty, Inc. (UPI) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts UPI Hot Sheet
Price: $1.22 --0%
Financial Fact:
Research and development: 665.54K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research and development: 665.54K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Uroplasty, Inc. (NASDAQ: UPI) reported Q3 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $6.7 million, versus $6.4 million reported last year.
For earnings history and earnings-related data on Uroplasty, Inc. (UPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
